+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Celltrion - logo

Celltrion manufacturers and sells biopharmaceutical and chemical medicines. Its best known products Remsima, a monoclonal antibody for the treatment of rheumatoid arthritis, ankylosing spondylitis, ulcerative colitis and adult Crohn's disease. Its antibody biosimilar pipeline includes CT-P10, CT-P17, CT-P16 and others. While its antibody biologics pipeline comprises CT-P27, CT-P26 and CT-P19. The company was founded in 2002 and is headquartered in Incheon, South Korea.

From
From
From
From
From
From
ESG Performance Analysis Report (2022) - Celltrion Pharm Inc. - Product Thumbnail Image

ESG Performance Analysis Report (2022) - Celltrion Pharm Inc.

  • Company Profile
  • July 2022
  • 30 Pages
ESG Performance Analysis Report (2022) - Celltrion, Inc. - Product Thumbnail Image

ESG Performance Analysis Report (2022) - Celltrion, Inc.

  • Company Profile
  • July 2022
  • 30 Pages
ESG Incident Analysis Report (2022) - Celltrion, Inc. - Product Thumbnail Image

ESG Incident Analysis Report (2022) - Celltrion, Inc.

  • Company Profile
  • July 2022
  • 30 Pages
Loading Indicator